In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children
Susan B. Brogly(Queen's University), George R. Seage(Unknown), Patrick Jean‐Philippe(Jackson Foundation), James M. Oleske(Rutgers, The State University of New Jersey), Nathalie Ylitalo(Harvard University), Michael T. Brady(Tulane University), Marilyn J. Crain(University of Alabama at Birmingham), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Michael D. Hughes(Virginia Tech), Mark J. Abzug(University of Colorado Denver), Russell Van Dyke(Cancer Research And Biostatistics)
Cited by 133
Related Papers
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697